Cervical cancer and digital cytology

That this House recognises that cervical cancer is preventable in over 99 per cent of cases, and that measures, including the HPV vaccine and cervical screenings, are key to its prevention; recognises that attending cervical screenings is crucial, and there are opportunities to improve the experience for both clinicians and patients through new, innovative technologies and approaches, including digital cytology; highlights NHS Monkland’s pioneering use of digital cytology, developed by the medical technology company, Hologic, which supports a more flexible and efficient cervical cancer screening programme; and encourages the wider adoption of digital cytology by NHS trusts throughout the UK to impact the effectiveness of cervical cancer screening.